scholarly article | Q13442814 |
P2093 | author name string | Raymund R Razonable | |
Robert A Brown | |||
Atul Humar | |||
Carlos V Paya | |||
Emma Covington | |||
Emma Alecock | |||
PV16000 Study Group | |||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Cytomegalovirus | Q6946 |
P304 | page(s) | 1331-1339 | |
P577 | publication date | 2005-09-14 | |
P1433 | published in | Journal of Infectious Diseases | Q4051141 |
P1476 | title | Herpesvirus infections in solid organ transplant patients at high risk of primary cytomegalovirus disease | |
P478 | volume | 192 |
Q55516321 | Advances in the Characterization of the T-Cell Response to Human Herpesvirus-6. |
Q90403930 | Co-infections of human herpesviruses (CMV, HHV-6, HHV-7 and EBV) in non-transplant acute leukemia patients undergoing chemotherapy |
Q54329294 | Confirmation of the low clinical effect of human herpesvirus-6 and -7 infections after renal transplantation. |
Q33276092 | Effect of cytomegalovirus prophylaxis with immunoglobulin or with antiviral drugs on post-transplant non-Hodgkin lymphoma: a multicentre retrospective analysis |
Q40205686 | Functionally inactivated dominant viral antigens of human cytomegalovirus delivered in replication incompetent adenovirus type 6 vectors as vaccine candidates |
Q40244415 | HHV-6: clinical and laboratory investigations and correlations with encephalitis in liver transplant recipients |
Q34293248 | Herpes zoster incidence in a multicenter cohort of solid organ transplant recipients |
Q40590036 | Herpesvirus Respiratory Infections in Immunocompromised Patients: Epidemiology, Management, and Outcomes. |
Q40068421 | Human herpes virus 6 infection in pediatric organ transplant patients |
Q37507814 | Human herpesvirus 6 infections after liver transplantation |
Q42272326 | Human herpesvirus 6, 7 and 8 in solid organ transplantation |
Q26823683 | Human herpesvirus-6 infections in kidney, liver, lung, and heart transplantation: review |
Q40259107 | Human herpesviruses 6, 7 and 8 in solid organ transplant recipients |
Q99634836 | Identification and Prevalence of Phascolarctid Gammaherpesvirus Types 1 and 2 in South Australian Koala Populations |
Q41139700 | Impact of human herpes virus 6 in liver transplantation |
Q37065216 | Improving outcomes for solid-organ transplant recipients at risk from cytomegalovirus infection: late-onset disease and indirect consequences |
Q37794618 | Infections due to human herpesvirus 6 in solid organ transplant recipients |
Q37803335 | Management of cytomegalovirus infection in solid organ transplantation |
Q37892559 | Management of viral infections in solid organ transplant recipients |
Q37848137 | Monitoring and managing viral infections in pediatric renal transplant recipients |
Q38097119 | Opportunistic viral infections in intestinal transplantation |
Q38456262 | Rabbit antithymocyte globulin induction and risk of post-transplant lymphoproliferative disease in adult and pediatric solid organ transplantation: An update |
Q35690503 | Relationship between cytomegalovirus DNA load in epithelial lining fluid and plasma of lung transplant recipients and analysis of coinfection with Epstein-Barr virus and human herpesvirus 6 in the lung compartment |
Q38256992 | Roseoloviruses in transplant recipients: clinical consequences and prospects for treatment and prevention trials |
Q35784500 | Simultaneous quantification of Epstein-Barr virus, cytomegalovirus, and human herpesvirus 6 DNA in samples from transplant recipients by multiplex real-time PCR assay. |
Q37773992 | Strategies for managing cytomegalovirus in transplant recipients |
Q35683931 | The pharmacokinetics of valganciclovir prophylaxis in pediatric solid organ transplant patients at risk for Epstein-Barr virus disease |
Q36724385 | Two strategies for prevention of cytomegalovirus infections after liver transplantation |
Q34635415 | VZV encephalitis following successful treatment of CMV infection in a patient with kidney transplant. |
Search more.